Praha, Czechia

Hana Chodounska

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hana Chodounska

Introduction

Hana Chodounska is a prominent inventor based in Praha, Czech Republic. She has made significant contributions to the field of neuroprotective compounds, with a focus on addressing various neuropsychiatric disorders. Her work has garnered attention for its potential therapeutic applications.

Latest Patents

Chodounska holds two notable patents. The first patent is for amphiphilic compounds with neuroprotective properties, specifically those with a tetradecahydrophenanthrene skeleton and their enantiomers. These compounds exhibit neuroprotective effects and are intended for use in treating neuropsychiatric disorders associated with an imbalance in the glutamatergic neurotransmitter system. This includes conditions such as ischemic damage of the central nervous system (CNS), neurodegenerative changes, affective disorders, depression, post-traumatic stress disorder, anxiety, schizophrenia, and more. The second patent involves steroid anionic compounds, detailing their production methods, usage, and pharmaceutical preparations that incorporate them.

Career Highlights

Throughout her career, Chodounska has worked with esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and the Institute of Physiology of the Czech Academy of Sciences. Her research has significantly advanced the understanding of neuroprotective agents and their applications in medicine.

Collaborations

Chodounska has collaborated with notable colleagues, including Vojtech Kapras and Ladislav Vyklicky. These partnerships have contributed to her innovative research and the development of her patented compounds.

Conclusion

Hana Chodounska's work in the field of neuroprotective compounds highlights her dedication to addressing critical neuropsychiatric disorders. Her patents reflect her innovative spirit and commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…